EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 40 filers reported holding EVELO BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $27,106 | – | 150,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 3,063,505 | $37,038,000 | 14.47% |
| Mayo Clinic | 484,953 | $5,863,000 | 7.05% |
| Flagship Pioneering Inc. | 22,900,069 | $276,862,000 | 5.04% |
| Trustees of Columbia University in the City of New York | 113,850 | $1,376,000 | 1.84% |
| Alphabet Inc. | 1,060,495 | $12,821,000 | 0.62% |
| Artal Group S.A. | 700,000 | $8,463,000 | 0.18% |
| Larson Financial Group LLC | 28,353 | $343,000 | 0.12% |
| PEDDOCK CAPITAL ADVISORS, LLC | 3,663 | $44,000 | 0.02% |
| CREDIT SUISSE AG/ | 2,705,511 | $32,710,000 | 0.02% |
| FMR LLC | 6,803,365 | $82,253,000 | 0.01% |